Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 17Unknown 12Recruiting 7Not yet recruiting 4Terminated 3Suspended 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 1Rectal Neoplasms 1Glioblastoma 1Eyelid Squamous Cell Carcinoma 1Carcinoma, Non-Small-Cell Lung 1Adenocarcinoma Of Esophagus 1

Interventions

S 1 (combination) 2Oxaliplatin 2Irinotecan 2vactosertib 1titanium silicide 1fludarabine phosphate 1aldesleukin 1Surgical Procedures, Operative 1Receptors, Chimeric Antigen 1Leucovorin 1Interleukin-2 1Infusions, Parenteral 1IL32 protein, human 1Hyperthermic Intraperitoneal Chemotherapy 1Fluorouracil 1Drug Therapy 1Docetaxel 1Cyclophosphamide 1Congresses as Topic 1Capecitabine 1Automobiles 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Suspended × Stomach Neoplasms × Surgical Procedures, Operative × Clear all
NCT02366819 2026-03-30

Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer

University of Chicago

Phase 4 Suspended
36 enrolled
Gastrointestinal

Adenocarcinoma Of Esophagus, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡